Track topics on Twitter Track topics that are important to you
Founded in 1987, Advanced Tissue Sciences (ATIS) has developed a technology to manufacture human-based tissues and organs for repair and transplantation. Focusing mainly on the therapeutic products, the Company's technologies have broad applications throughout the traditional healing and transplant markets. Advanced Tissue Sciences is focusing on two cell types, fibroblasts (connective tissue cells) and chondrocytes (cartilage cells).
10933 North Torrey Pines Road
United States of America
[Articles] Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Doxorubicin should remain the standard first-line treatment for most patients with advanced soft-tissue sarcoma. These results provide evidence for clinicians to consider with their patients when sele...
In this interview we discuss the phase III trial of aldoxorubicin in patients with advanced soft-tissue sarcoma, which showed improved efficacy and reduced toxicity over doxorubicin.
[Articles] Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
The addition of evofosfamide to doxorubicin as first-line therapy did not improve overall survival compared with single-drug doxorubicin in patients with locally advanced, unresectable, or metastatic ...
ArticleA team from Northwestern University has developed a novel type of bioactive tissue that is thin and flexible enough to be folded into ‘origami-like’ shapes.
ArticleAfter being implanted in the abdomen, the tiny structures expanded 50-fold and were able to perform normal liver tissue functions.
This case series of patients with advanced cancer evaluates the proportion and potential clinical implications of inherited variants detected using DNA sequencing of tumor and normal tissue compared w...
ArticleScientists have tapped into the body’s natural healing process to develop a new method to repair damaged tissue.
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...
Rheumatoid arthritis (RA) patients are at increased risk of suffering from adverse cardiovascular events. Cardiovascular magnetic resonance (CMR) mapping techniques might be appropriate tools to compl...
To evaluate the relationship between body mass index (BMI) and rates of treatment tolerance and clinical outcomes in patients with locally advanced rectal cancer treated with a multimodality approach.
Tissue engineering has become a new promising strategy for repairing damaged organs of the urinary system, including the bladder. The basic idea of tissue engineering is to integrate cellular technolo...
Limited evidence suggests that female breast tissue ages faster than other parts of the body according to an epigenetic biomarker of aging known as the "epigenetic clock." However, it is unknown wheth...
Research in tissue engineering has undoubtedly achieved significant milestones in recent years. Although it is being applied in several disciplines, tissue engineering's application is particularly ad...
Primary Objective: 1. To evaluate the efficacy of glufosfamide in subjects with advanced soft tissue sarcoma as measured by objective response rate Secondary Objectives: 1...
The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.
The purpose of this study is to determine whether TH-302 in combination with Doxorubicin is safe and effective in the treatment of Advanced Soft Tissue Sarcoma.
The purpose of the study is to determine the safety and efficacy of single agent CC-4047 in patients with advanced soft tissue sarcomas who have relapsed or are refractory to prior antican...
Patients with advanced soft tissue sarcoma(rhabdomyosarcoma and liposarcoma excluded), who experience progression after standard chemotherapy, have limited treatment options which promise ...
Founded in 1987, Advanced Tissue Sciences (ATIS) has developed a technology to manufacture human-based tissues and organs for repair and transplantation. Focusing mainly on the therapeutic products, t...
Advanced Tissue Sciences, Inc. is a leading tissue engineering company engaged in the development of human-based tissue products for therapeutic applications. The Company is currently focusing its ef...
Reveal Biosciences is a leading contract research organization that specializes in advanced tissue technology services and tissue-based research. Their portfolio of services inclu...
Tissue Engineering Sciences, Inc was incorporated in 1997 to develop novel bioreactor and automated support systems for in vitro and in vivo cell and tissue engineering applications. The TES R&D team ...
SQI Diagnostics is a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Companyâs proprieta...
We have published hundreds of Advanced Tissue Sciences Incorporated news stories on BioPortfolio along with dozens of Advanced Tissue Sciences Incorporated Clinical Trials and PubMed Articles about Advanced Tissue Sciences Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Tissue Sciences Incorporated Companies in our database. You can also find out about relevant Advanced Tissue Sciences Incorporated Drugs and Medications on this site too.
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...